Pacira BioSciences
PCRX
PCRX
266 hedge funds and large institutions have $1.89B invested in Pacira BioSciences in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 105 increasing their positions, 81 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 45
2% less funds holding
Funds holding: 272 → 266 (-6)
4.7% less ownership
Funds ownership: 105.57% → 100.87% (-4.7%)
Holders
266
Holding in Top 10
2
Calls
$7.27M
Puts
$6.19M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$19.6M | |
| 3 | +$17.8M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$12.5M |
| 5 |
BlackRock
New York
|
+$10.7M |
Top Sellers
| 1 | -$73.1M | |
| 2 | -$48.9M | |
| 3 | -$32.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.6M |
| 5 |
DM
Deerfield Management
New York
|
-$11.3M |